Imogen's Canine Theracare Ltd 15151078 false 2024-10-01 2025-09-30 2025-09-30 The principal activity of the company is Canine Therapy Digita Accounts Production Advanced 6.30.9574.0 true 15151078 2024-10-01 2025-09-30 15151078 2025-09-30 15151078 bus:OrdinaryShareClass1 bus:CumulativeShares 2025-09-30 15151078 core:CurrentFinancialInstruments 2025-09-30 15151078 core:CurrentFinancialInstruments core:WithinOneYear 2025-09-30 15151078 core:Non-currentFinancialInstruments 2025-09-30 15151078 core:Non-currentFinancialInstruments core:AfterOneYear 2025-09-30 15151078 core:FurnitureFittingsToolsEquipment 2025-09-30 15151078 core:OtherPropertyPlantEquipment 2025-09-30 15151078 bus:SmallEntities 2024-10-01 2025-09-30 15151078 bus:AuditExemptWithAccountantsReport 2024-10-01 2025-09-30 15151078 bus:FilletedAccounts 2024-10-01 2025-09-30 15151078 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 15151078 bus:RegisteredOffice 2024-10-01 2025-09-30 15151078 bus:Director1 2024-10-01 2025-09-30 15151078 bus:OrdinaryShareClass1 bus:CumulativeShares 2024-10-01 2025-09-30 15151078 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 15151078 bus:Agent1 2024-10-01 2025-09-30 15151078 core:ComputerEquipment 2024-10-01 2025-09-30 15151078 core:FurnitureFittingsToolsEquipment 2024-10-01 2025-09-30 15151078 core:OtherPropertyPlantEquipment 2024-10-01 2025-09-30 15151078 core:PlantMachinery 2024-10-01 2025-09-30 15151078 countries:England 2024-10-01 2025-09-30 15151078 2024-09-30 15151078 core:FurnitureFittingsToolsEquipment 2024-09-30 15151078 core:OtherPropertyPlantEquipment 2024-09-30 15151078 2023-09-20 2024-09-30 15151078 2024-09-30 15151078 bus:OrdinaryShareClass1 bus:CumulativeShares 2024-09-30 15151078 core:CurrentFinancialInstruments 2024-09-30 15151078 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 15151078 core:Non-currentFinancialInstruments 2024-09-30 15151078 core:Non-currentFinancialInstruments core:AfterOneYear 2024-09-30 15151078 core:FurnitureFittingsToolsEquipment 2024-09-30 15151078 core:OtherPropertyPlantEquipment 2024-09-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 15151078

Imogen's Canine Theracare Ltd
Unaudited Filleted Financial Statements
for the Year Ended 30 September 2025

Imogen's Canine Theracare Ltd

Contents

Company Information | 1
Balance Sheet | 2 to 3
Notes to the Unaudited Financial Statements | 4 to 9

Imogen's Canine Theracare Ltd

Company Information

Director | Miss Imogen Amy Victoria Pattison

Registered office | Christmas Cottage 3 Ayot Green Ayot St Peter Welwyn Hertfordshire AL6 9AB

Accountants | RS Partnership Ltd Chartered Certified Accountants10 Prospect Place Welwyn Hertfordshire AL6 9EW

Imogen's Canine Theracare Ltd

(Registration number: 15151078)
Balance Sheet as at 30 September 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Tangible assets | 4 | 33,716 | 34,760
Current assets |  |  |
Stocks | 5 | 2,500 | 2,500
Debtors | 6 | 2,751 | 5,788
Cash at bank and in hand |  | 20,216 | 5,214
|  | 25,467 | 13,502
Creditors: Amounts falling due within one year | 7 | (38,685) | (39,898)
Net current liabilities |  | (13,218) | (26,396)
Total assets less current liabilities |  | 20,498 | 8,364
Creditors: Amounts falling due after more than one year | 7 | (6,504) | (7,082)
Provisions for liabilities |  | (3,608) | (243)
Net assets |  | 10,386 | 1,039
Capital and reserves |  |  |
Called up share capital | 8 | 2 | 2
Retained earnings |  | 10,384 | 1,037
Shareholders' funds |  | 10,386 | 1,039

For the financial year ending 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 23 April 2026

Imogen's Canine Theracare Ltd

(Registration number: 15151078)
Balance Sheet as at 30 September 2025

......................................... Miss Imogen Amy Victoria Pattison Director

Imogen's Canine Theracare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2025

1 | General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Christmas Cottage
3 Ayot Green
Ayot St Peter
Welwyn
Hertfordshire
AL6 9AB

The principal place of business is:
135D London Road
Knebworth
SG3 6EX

These financial statements were authorised for issue by the director on 23 April 2026.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

These financial statements are presented in Pounds Sterling (£), which is the Company’s functional
currency. All amounts have been rounded to the nearest pound, unless otherwise indicated.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Imogen's Canine Theracare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2025

Tax

The tax expense for the period comprises deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.
Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Plant and machinery | 20% Reducing balance
Computer equipment | 33.33% Straight Line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Imogen's Canine Theracare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2025

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.
The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.
Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.
Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2024 - 1).

Imogen's Canine Theracare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2025

4 | Tangible assets

| Furniture, fittings and equipment £ | Other property, plant and equipment £ | Total £
Cost or valuation
At 1 October 2024 | 3,021 | 36,208 | 39,229
Additions | - | 7,200 | 7,200
At 30 September 2025 | 3,021 | 43,408 | 46,429
Depreciation
At 1 October 2024 | 245 | 4,224 | 4,469
Charge for the year | 1,007 | 7,237 | 8,244
At 30 September 2025 | 1,252 | 11,461 | 12,713
Carrying amount
At 30 September 2025 | 1,769 | 31,947 | 33,716
At 30 September 2024 | 2,776 | 31,984 | 34,760

5 | Stocks

| 2025 £ | 2024 £
Finished goods and goods for resale | 2,500 | 2,500

6 | Debtors

| 2025 £ | 2024 £
Prepayments | 1 | 5,788
Other debtors | 2,750 | -
| 2,751 | 5,788

Imogen's Canine Theracare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2025

7 | Creditors

Creditors: amounts falling due within one year

| Note | 2025 £ | 2024 £
Due within one year |  |  |
Bank loans and overdrafts | 9 | 2,499 | 17,491
Trade creditors |  | 288 | -
Accruals and deferred income |  | 5,875 | 875
Other creditors |  | 1,009 | -
Directors Loan Account |  | 29,014 | 21,532
|  | 38,685 | 39,898

Creditors: amounts falling due after more than one year

| Note | 2025 £ | 2024 £
Due after one year |  |  |
Loans and borrowings | 9 | 6,504 | 7,082

8 | Share capital

Allotted, called up and fully paid shares

| 2025 | 2024
| No. | £ | No. | £
Ordinary £1.00 Shares of £1 each | 2 | 2 | 2 | 2

9 | Loans and borrowings

Non-current loans and borrowings

| 2025 £ | 2024 £
Bank borrowings | 6,504 | 7,082

Current loans and borrowings

Imogen's Canine Theracare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2025

| 2025 £ | 2024 £
Bank borrowings | 2,499 | 15,005
Other borrowings | - | 2,486
| 2,499 | 17,491